Top Feature

Aug 06, 2018
Pharmaceutical Executive
Over the last decade, Spain has seen a significant growth in venture-capital investment in the life sciences. We explore the driving forces.
Jul 10, 2018
Pharmaceutical Executive
PharmExec talks to Dr. Gil Van Bokkelen, co-founder of Athersys, a company looking to forge new advances in the stem cell arena.
Jul 10, 2018
Pharmaceutical Executive
Pharm Exec convenes an expert panel to discuss new ways to navigate the many complexities of assessing business and risk in the life sciences.
Jul 07, 2018
Pharmaceutical Executive
Peter Young explores the prospects—and related challenges—for Chinese life science as it aggressively pursues new growth areas.
Jun 19, 2018
Pharmaceutical Executive
Pharm Exec speaks with Joe Wiley, CEO of Amryt Pharma, who is steering a road-less-traveled path for a small pharma—building a sustainable, commercial infrastructure first, with the hopes of accelerating new rare disease drugs to the market.
Jun 18, 2018
Pharmaceutical Executive
Exploring new character benchmarks for today’s pharma executives, and whether they have the transformational traits to lead through change.
Jun 11, 2018
Pharmaceutical Executive
Laboratory testing has become a critical access point for sales teams in the age of personalized medicine, writes Melissa Leonhauser.
May 22, 2018
Pharmaceutical Executive
In its 12th annual feature, Pharm Exec profiles a new round of biopharma products that are making waves in five key areas in healthcare and R&D.
May 09, 2018
Pharmaceutical Executive
Meeting the stringent cloud compliance and regulatory requirements in pharma. 
May 08, 2018
Pharmaceutical Executive
Pharm Exec speaks with Tim Sullivan, who brings that sought-after melding of business and scientific perspectives to his role as chief financial officer for Apellis.
native1_300x100
lorem ipsum